Results 21 to 30 of about 486,688 (369)
High-Throughput Precision Phenotyping of Left Ventricular Hypertrophy with Cardiovascular Deep Learning [PDF]
, 2021 Left ventricular hypertrophy (LVH) results from chronic remodeling caused by a broad range of systemic and cardiovascular disease including hypertension, aortic stenosis, hypertrophic cardiomyopathy, and cardiac amyloidosis. Early detection and characterization of LVH can significantly impact patient care but is limited by under-recognition of ...
arxiv +1 more source
The Role of Chondrocyte Hypertrophy and Senescence in Osteoarthritis Initiation and Progression
International Journal of Molecular Sciences, 2020 Osteoarthritis (OA) is the most common joint disease that causes pain and disability in the adult population. OA is primarily caused by trauma induced by an external force or by age-related cartilage damage.
Yeri Alice Rim, Yoojun Nam, J. Ju
semanticscholar +1 more source
Frontiers in Physiology, 2017 Skeletal muscle mass is a result of the balance between protein breakdown and protein synthesis. It has been shown that multiple conditions of muscle atrophy are characterized by the common regulation of a specific set of genes, termed atrogenes.
Marcelo G. Pereira +16 more
doaj +1 more source
Unilateral lateral mass hypertrophy: An extremely rare congenital anomaly of Atlas
Journal of Craniovertebral Junction and Spine, 2013 A wide variety of congenital anomalies are observed around the craniovertebral junctional area. However, hypertrophied unilateral lateral mass of atlas in association with chiari-1 malformation leading to myelopathy is extremely uncommon.
Kuntal Kanti Das +5 more
doaj +1 more source
An Overview of Glycosylation and its Impact on Cardiovascular Health and Disease
Frontiers in Molecular Biosciences, 2021 The cardiovascular system is a complex and well-organized system in which glycosylation plays a vital role. The heart and vascular wall cells are constituted by an array of specific receptors; most of them are N- glycosylated and mucin-type O ...
Karen Julissa Loaeza-Reyes +11 more
doaj +1 more source
Frontiers in Physiology, 2018 Background: Yiqifumai Injection (YQFM) is clinically used to treat various cardiovascular diseases including chronic heart failure (CHF). The efficacy of YQFM for treating heart failure has been suggested, but the mechanism of action for pharmacological ...
Yu Zhao +7 more
doaj +1 more source
Case Report: Hepatic Artery Infusion Chemotherapy After Stage I ALPPS in a Patient With Huge HCC
Frontiers in Surgery, 2021 Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) can induce rapid hypertrophy of the liver remnant. However, with a background of liver cirrhosis or other chronic liver diseases, patients with a huge hepatocellular ...
Wenfeng Zhuo +5 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Individuals affected by Huntington's disease (HD) present with progressive degeneration that results in a wide range of symptoms, including cardiovascular (CV) dysfunction.
Saemi Park +11 more
doaj +1 more source
Physiological Reports, 2021 Intermittent hypoxia (IH) is a feature of obstructive sleep apnea (OSA), a condition highly associated with hypertension‐related cardiovascular diseases.
Bruna Visniauskas +6 more
doaj +1 more source
European Heart Journal, 2016 AIMS Sustained cardiac hypertrophy accompanied by maladaptive cardiac remodelling represents an early event in the clinical course leading to heart failure. Maladaptive hypertrophy is considered to be a therapeutic target for heart failure.
Kun Wang +14 more
semanticscholar +1 more source